P30613 (KPYR_HUMAN) Homo sapiens (Human)
Pyruvate kinase PKLR UniProtKBInterProSTRINGInteractive Modelling
574 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
However, an attempt to improve models for this target was made on 2025-05-10. The outcome - failed for technical reasons.
Available Structures
50 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of liver pyruvate kinase in complex with allosteric modulator 15 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O9I; | |||
| Structure of human liver pyruvate kinase from which the B domain has been deleted |
Heteromer | 100 | 4×FBP; 4×OXD; 4×MG; 4×K; 3×NA; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 42 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×I9N; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 22 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×OB0; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 4 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 4×OA0; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 44 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×OD9; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 17 |
Heteromer | 100 | 4×FBP; 4×OXL; 2×E6K; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 28 |
Heteromer | 100 | 4×FBP; 4×OXL; 3×I7V; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 5 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O88; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 42 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×ODL; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 11 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O8F; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 57 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 1×I8Q; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 24 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×OCU; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 36 |
Heteromer | 100 | 4×FBP; 4×OXL; 2×I7N; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 101 |
Heteromer | 100 | 4×FBP; 4×OXL; 3×I99; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 15 |
Heteromer | 100 | 4×FBP; 4×OXL; 3×I9Q; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 6 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×Y0T; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 47 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 3×I4L; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 3 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×OD5; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 58 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×I8U; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 7 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O99; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 100 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 1×I9C; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 21 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O7F; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 1 |
Heteromer | 100 | 4×FBP; 4×OXL; 3×AZN; 4×MG; 4×K; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 55 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×I8Y; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 105 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 1×I9F; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 17 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O8O; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 99 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×I91; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 16 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O9R; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 18 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 6×Y3Z; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 106 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×I9K; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 13 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O7X; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 8 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×O8X; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 41 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 2×OE0; | |||
| Structure of liver pyruvate kinase in complex with allosteric modulator 20 |
Heteromer | 100 | 4×FBP; 4×OXL; 4×MG; 4×K; 1×OAT; | |||
| Structure of liver pyruvate kinase in complex with anthraquinone derivative 29 |
Heteromer | 100.0 | 4×FBP; 4×OXL; 3×I7K; 5×MG; | |||
| The structure of human liver pyruvate kinase, hLPYK-S531E | homo-4-mer | 99.8 | 24×EDO; | |||
| The structure of C436M-hLPYK in complex with Citrate/Mn/ATP/Fru-1,6-BP | homo-4-mer | 99.62 | 4×MN; 4×FLC; 4×FBP; 1×EDO; 1×ADN; | |||
| The structure of human liver pyruvate kinase, hLPYK-D499N, in complex with Fru-1,6-BP | homo-4-mer | 99.76 | 4×FBP; 7×EDO; 4×PEP; | |||
| The structure of human liver pyruvate kinase, hLPYK-GGG | homo-4-mer | 100.0 | 12×EDO; 6×GOL; 2×FLC; | |||
| The structure of human liver pyruvate kinase, hLPYK-W527H | homo-4-mer | 99.76 | 12×GOL; 10×EDO; | |||
| Structure of human erythrocyte pyruvate kinase in complex with an allosteric activator Compound 12 | homo-4-mer | 100.0 | 2×I0R; 3×PYR; 4×FBP; 4×MN; 2×K; | |||
| Structure of human erythrocyte pyruvate kinase in complex with an allosteric activator AG-946 | homo-4-mer | 100.0 | 4×FBP; 4×MN; 3×K; 4×PYR; 2×HVI; | |||
| Structure of the S12D variant of human liver pyruvate kinase in complex with citrate and FBP. | homo-4-mer | 100.0 | 4×MN; 4×FLC; 4×FBP; 9×EDO; 2×PEG; 4×NA; 2×1PE; 1×ADN; | |||
| Structure of human erythrocyte pyruvate kinase in complex with an allosteric activator Compound 2 | homo-4-mer | 100.0 | 4×FBP; 4×PYR; 4×MN; 4×K; 2×I07; | |||
| Crystal structure of pyruvate kinase tetramer in complex with allosteric activator, Mitapivat (MTPV… | homo-4-mer | 100.0 | 4×MG; 4×FBP; 2×WV2; | |||
| HUMAN ERYTHROCYTE PYRUVATE KINASE | homo-4-mer | 100 | 4×FBP; 4×PGA; 4×K; 4×MN; | |||
| HUMAN ERYTHROCYTE PYRUVATE KINASE: R479H MUTANT | homo-4-mer | 99.8 | 4×FBP; 4×PGA; 4×K; 4×MN; | |||
| HUMAN ERYTHROCYTE PYRUVATE KINASE: T384M mutant | homo-4-mer | 99.81 | 4×FBP; 4×PGA; 4×K; 4×MN; | |||
| HUMAN ERYTHROCYTE PYRUVATE KINASE: R486W MUTANT | homo-4-mer | 99.81 | 4×FBP; 4×PGA; 4×K; 4×MN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6eck.1.C | homo-4-mer | 0.85 | 2×FLC; | 92.80 | ||
| 7qdn.1.A | homo-4-mer | 0.68 | 3×K; | 85.09 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6eck.1.C | homo-4-mer | 0.85 | 2×FLC; | 93.00 | ||
| Isoform 2 | 7qdn.1.A | homo-4-mer | 0.63 | 3×K; | 86.79 | ||